These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

960 related items for PubMed ID: 27529566

  • 1. Differences in Breast Milk Composition of HIV-Infected and HIV-Uninfected Mothers of Premature Infants: Effects of Antiretroviral Therapy.
    Fouché C, van Niekerk E, du Plessis LM.
    Breastfeed Med; 2016 Nov; 11():455-460. PubMed ID: 27529566
    [Abstract] [Full Text] [Related]

  • 2. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
    Palombi L, Marazzi MC, Voetberg A, Magid NA.
    AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
    [Abstract] [Full Text] [Related]

  • 3. Breastmilk Output in a Disadvantaged Community with High HIV Prevalence as Determined by the Deuterium Oxide Dose-to-Mother Technique.
    Mulol H, Coutsoudis A.
    Breastfeed Med; 2016 Mar; 11(2):64-9. PubMed ID: 26862660
    [Abstract] [Full Text] [Related]

  • 4. Longitudinal adherence to maternal antiretroviral therapy and infant Nevirapine prophylaxis from 6 weeks to 18 months postpartum amongst a cohort of mothers and infants in South Africa.
    Larsen A, Magasana V, Dinh TH, Ngandu N, Lombard C, Cheyip M, Ayalew K, Chirinda W, Kindra G, Jackson D, Goga A.
    BMC Infect Dis; 2019 Sep 16; 19(Suppl 1):789. PubMed ID: 31526366
    [Abstract] [Full Text] [Related]

  • 5. Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.
    Gibb DM, Kizito H, Russell EC, Chidziva E, Zalwango E, Nalumenya R, Spyer M, Tumukunde D, Nathoo K, Munderi P, Kyomugisha H, Hakim J, Grosskurth H, Gilks CF, Walker AS, Musoke P, DART trial team.
    PLoS Med; 2012 Sep 16; 9(5):e1001217. PubMed ID: 22615543
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of HIV-1 drug resistance amongst newly diagnosed HIV-infected infants age 4-8 weeks, enrolled in three nationally representative PMTCT effectiveness surveys, South Africa: 2010, 2011-12 and 2012-13.
    Hunt GM, Ledwaba J, Salimo A, Kalimashe M, Dinh TH, Jackson D, Sherman G, Puren A, Ngandu NK, Lombard C, Morris L, Goga A.
    BMC Infect Dis; 2019 Sep 16; 19(Suppl 1):787. PubMed ID: 31526373
    [Abstract] [Full Text] [Related]

  • 7. Infectious morbidity of breastfed, HIV-exposed uninfected infants under conditions of universal antiretroviral therapy in South Africa: a prospective cohort study.
    le Roux SM, Abrams EJ, Donald KA, Brittain K, Phillips TK, Zerbe A, le Roux DM, Kroon M, Myer L.
    Lancet Child Adolesc Health; 2020 Mar 16; 4(3):220-231. PubMed ID: 31932246
    [Abstract] [Full Text] [Related]

  • 8. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    Kesho Bora Study Group, de Vincenzi I.
    Lancet Infect Dis; 2011 Mar 16; 11(3):171-80. PubMed ID: 21237718
    [Abstract] [Full Text] [Related]

  • 9. Levels of Total Antioxidant Capacity, sCD14, and TGF-β2 in Breast Milk Plasma of HIV-Infected and HIV-Uninfected Lactating Women.
    Mabaya L, Matarira HT, Tanyanyiwa DM, Musarurwa C, Mukwembi J.
    Breastfeed Med; 2021 Oct 16; 16(10):821-826. PubMed ID: 34010029
    [Abstract] [Full Text] [Related]

  • 10. Anthropometric Parameters of HIV-Infected and HIV-Uninfected Mothers and their Premature Infants.
    Fouché C, van Niekerk E, du Plessis LM.
    J Trop Pediatr; 2018 Aug 01; 64(4):255-261. PubMed ID: 28985403
    [Abstract] [Full Text] [Related]

  • 11. Two-year morbidity-mortality and alternatives to prolonged breast-feeding among children born to HIV-infected mothers in Côte d'Ivoire.
    Becquet R, Bequet L, Ekouevi DK, Viho I, Sakarovitch C, Fassinou P, Bedikou G, Timite-Konan M, Dabis F, Leroy V, ANRS 1201/1202 Ditrame Plus Study Group.
    PLoS Med; 2007 Jan 01; 4(1):e17. PubMed ID: 17227132
    [Abstract] [Full Text] [Related]

  • 12. Antiretroviral drugs to prevent mother-to-child transmission of HIV during breastfeeding.
    Shetty AK, Maldonado Y.
    Curr HIV Res; 2013 Mar 01; 11(2):102-25. PubMed ID: 23432487
    [Abstract] [Full Text] [Related]

  • 13. Exclusive Breastfeeding Is More Common Among HIV-Infected Than HIV-Uninfected Kenyan Mothers at 6 Weeks and 6 Months Postpartum.
    Oiye S, Mwanda W, Mugambi M, Filteau S, Owino V.
    Breastfeed Med; 2017 Jun 01; 12():283-289. PubMed ID: 28467097
    [Abstract] [Full Text] [Related]

  • 14. Antibodies against pneumococcal capsular polysaccharide in Malawian HIV-positive mothers and their HIV-exposed uninfected children.
    Baroncelli S, Galluzzo CM, Mancinelli S, Andreotti M, Jere H, Amici R, Marazzi MC, Vella S, Palombi L, Giuliano M.
    Infect Dis (Lond); 2016 Apr 01; 48(4):317-321. PubMed ID: 26609569
    [Abstract] [Full Text] [Related]

  • 15. Growth trajectories of breastfed HIV-exposed uninfected and HIV-unexposed children under conditions of universal maternal antiretroviral therapy: a prospective study.
    le Roux SM, Abrams EJ, Donald KA, Brittain K, Phillips TK, Nguyen KK, Zerbe A, Kroon M, Myer L.
    Lancet Child Adolesc Health; 2019 Apr 01; 3(4):234-244. PubMed ID: 30773459
    [Abstract] [Full Text] [Related]

  • 16. Infant Human Immunodeficiency Virus-free Survival in the Era of Universal Antiretroviral Therapy for Pregnant and Breastfeeding Women: A Community-based Cohort Study From Rural Zambia.
    Chi BH, Mutale W, Winston J, Phiri W, Price JT, Mwiche A, Ayles H, Stringer JSA.
    Pediatr Infect Dis J; 2018 Nov 01; 37(11):1137-1141. PubMed ID: 29601456
    [Abstract] [Full Text] [Related]

  • 17. Impact of Timing of Antiretroviral Treatment and Birth Weight on Mother-to-Child Human Immunodeficiency Virus Transmission: Findings From an 18-Month Prospective Cohort of a Nationally Representative Sample of Mother-Infant Pairs During the Transition From Option A to Option B+ in Zimbabwe.
    Dinh TH, Mushavi A, Shiraishi RW, Tippett Barr B, Balachandra S, Shambira G, Nyakura J, Zinyowera S, Tshimanga M, Mugurungi O, Kilmarx PH.
    Clin Infect Dis; 2018 Feb 01; 66(4):576-585. PubMed ID: 29401270
    [Abstract] [Full Text] [Related]

  • 18. Support for relactation among mothers of HIV-infected children: a pilot study in Soweto.
    Nyati M, Kim HY, Goga A, Violari A, Kuhn L, Gray G.
    Breastfeed Med; 2014 Nov 01; 9(9):450-7. PubMed ID: 25188674
    [Abstract] [Full Text] [Related]

  • 19. The effect of human immunodeficiency virus infection on birthweight, and infant and child mortality in urban Malawi.
    Taha TE, Dallabetta GA, Canner JK, Chiphangwi JD, Liomba G, Hoover DR, Miotti PG.
    Int J Epidemiol; 1995 Oct 01; 24(5):1022-9. PubMed ID: 8557435
    [Abstract] [Full Text] [Related]

  • 20. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
    Kowalska A, Niemiec T, El Midaoui A, Burkacka E.
    Med Wieku Rozwoj; 2003 Oct 01; 7(4 Pt 1):459-68. PubMed ID: 15010556
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.